Minoxidil
Alocutan, Alopexy, Loniten, Minoxidil Bio-H-Tin-Pharma · ATC code D11AX01
Also known as: Minoksidil · Brand names: Alocutan, Alopexy, Loniten, Minoxidil Bio-H-Tin-Pharma, Minoxidil Dermapharm, Minoxidil Doppelherzpharma Männer, Minoxidil Frauen Doppelherzpharma, Minoxidil Männer Doppelherzpharma, Minoxidil Redcare, Minoxipel, Regaine, Lonolox, Minoxicutan Frauen, Minoxicutan Mãnner, Regaine Frauen …
- Key facts
- Active substance
- Minoxidil
- ATC code
- D11AX01
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-10-27
Boxed warning
Minoxidil tablets contain the powerful antihypertensive agent, minoxidil, which may produce serious adverse effects. It can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated. Minoxidil should be reserved for hypertensive patients who do not respond adequately to maximum therapeutic doses of a diuretic and two other antihypertensive agents.
In experimental animals, minoxidil caused several kinds of myocardial lesions as well as other adverse cardiac effects (see Cardiac Lesions in Animals).
Minoxidil must be administered under close supervision, usually concomitantly with therapeutic doses of a beta-adrenergic blocking agent to prevent tachycardia and increased myocardial workload. It must also usually be given with a diuretic, frequently one acting in the ascending limb of the loop of Henle, to prevent serious fluid accumulation. Patients with malignant hypertension and those already receiving guanethidine (see WARNINGS) should be hospitalized when minoxidil is first administered so that they can be monitored to avoid too rapid, or large orthostatic, decreases in blood pressure.
Key facts
Minoxidil tablets contain a direct-acting peripheral vasodilator indicated, per the US prescribing information, only for severe hypertension not manageable with other drugs.
What it is used for
- Symptomatic hypertension or hypertension with target organ damage not manageable with maximum doses of a diuretic plus two other antihypertensive drugs
- Not recommended in milder degrees of hypertension
Dosing
- Over 12 years: start 5 mg once daily, increase to 10 mg, 20 mg and then 40 mg if required; usual range 10 to 40 mg per day, maximum 100 mg per day
- Under 12 years: start 0.2 mg/kg once daily; usual range 0.25 to 1.0 mg/kg/day, maximum 50 mg daily
- Dose adjustments at intervals of at least 3 days
- Usually given with a beta-blocker and a diuretic (frequently a loop diuretic)
Contraindications
- Pheochromocytoma
- Hypersensitivity to any component
Important warnings
- Boxed warning: can cause pericardial effusion, occasionally progressing to tamponade, and may exacerbate angina pectoris
- Salt and water retention up to congestive heart failure; adequate diuretic required, monitor body weight closely
- Patients with malignant hypertension or on guanethidine should be hospitalized at initiation
- Pericarditis has been reported
Side effects
- Hypertrichosis in about 80% of patients, developing within 3 to 6 weeks
- Edema, pericardial effusion and tamponade
- ECG T-wave changes, usually without symptoms
- Rare: rashes including Stevens-Johnson syndrome, thrombocytopenia, leukopenia
Interactions
- Guanethidine: risk of large orthostatic blood pressure falls; hospital initiation
Pregnancy and breastfeeding
- Increased fetal resorption in rabbits; effects in humans not adequately studied
- Excreted in breast milk; should not be administered to a nursing woman
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Austria
- AlocutanDermapharm Gmbh · 1 register entry
- AlopexyPierre Fabre Medicament · 1 register entry
- LonitenPfizer Corporation Austria Ges.M.B.H. · 1 register entry
- Minoxidil Bio-H-Tin-PharmaBio-H-Tin Pharma Gmbh · 1 register entry
- Minoxidil DermapharmDermapharm Ag · 1 register entry
- Minoxidil Doppelherzpharma MännerDoppelherz Pharma Gmbh · 1 register entry
- Minoxidil Frauen DoppelherzpharmaDoppelherz Pharma Gmbh · 1 register entry
- Minoxidil Männer DoppelherzpharmaDoppelherz Pharma Gmbh · 1 register entry
- Minoxidil RedcareRc Pharma B.V. · 1 register entry
- MinoxipelPelpharma Handels Gmbh · 1 register entry
- RegaineKenvue Austria Gmbh · 2 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- AlopexyPierre Fabre Medicament · 1 register entry
- LonoloxPfizer Pharma Gmbh · 1 register entry
- Minoxicutan FrauenDermapharm Ag · 1 register entry
- Minoxicutan MãnnerDermapharm Ag · 1 register entry
- MinoxidilPoa Pharma Scandinavia Ab, Doppelherz Pharma Gmbh, Careforsons Ireland Limited, Bio-H-Tin Pharma Gmbh, Kappler Pharma Consult Gmbh, Rc Pharma B.V., Aristo Pharma Gmbh (Art 57), Axunio Pharma Gmbh, Dexcel Pharma Gmbh, Klinge Pharma Gmbh · 14 register entries
- Regaine FrauenKenvue Germany Gmbh · 2 register entries
- Regaine MännerKenvue Germany Gmbh · 2 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- Alopexy TPIERRE FABRE DERMO KOZMETİK LTD. ŞTİ. · 1 register entry
- AndroviumASSOS İLAÇ KİMYA GIDA ÜRÜNLERİ ÜRETİM VE TİC. A.Ş. · 8 register entries
- Bioxinin ForteBİOTA BİTKİSEL İLAÇ VE KOZMETİK LABORATUARLARI A.Ş. · 2 register entries
- DerminoORVA İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- FoamixAVRUPA İLAÇ VE KOZMETİK SAN. TİC. A.Ş. · 2 register entries
- Minodermo FortDERMOTEK İLAÇ GIDA VE DERMOKOZMETİK SAN.TİC. LTD. ŞTİ. · 1 register entry
- MinoxilHUMANİS SAĞLIK A.Ş. · 2 register entries
- Noxdyl %ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- Noxdyl Fort %ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- R-Ger FortDROGSAN İLAÇLARI SAN. VE TİC. A.Ş. · 1 register entry
- RoganKOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. · 4 register entries
- Sabbia %AUGUSTUS İLAÇ MÜHENDİSLİĞİ SAN.TİC.İTH.İHR.LTD. ŞTİ. · 1 register entry
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 26 more European countries
- Belgium
- Alopexy, Minoxidil Biorga, Minoxidil Leman
- Bulgaria
- Миноксидил Епсилон Хелт, Регаин, Ремино
- Croatia
- Alomax, Regaine
- Cyprus
- Androxil, Botafex, Dinoxil, Regaine
- Czechia
- Belohair, Minorga, Minoxidil Miowell
- Denmark
- Lotorin, Minoxidil Intermed, Regaine Forte, Rylaxtol
- Estonia
- Regaine, Tricovivax
- Finland
- Lotorin, Minoxidil Orion, Rogaine, Rylaxtol, Tricovivax
- France
- Alopexy, Alostil, Lonoten, Lotorin, Minoxidil Bailleul, Minoxidil Biogaran Conseil, Minoxidil Cooper, Minoxidil Sandoz Conseil, Minoxidil Viatris, Neoxidil
- Greece
- Alopexy, Androxil, Axelan, Benevril, Botafex, Hairway, Lotorin, Minodril, Minoxidil Evdermia, Minoxidil Target, Regaine
- Hungary
- Brillaton, Minoxidil Miowell, Regaine
- Ireland
- Loniten, Minoxidil For Men Careforsons Ireland, Regaine Extra Strength, Regaine For Men Extra Strength Scalp Foam, Regaine For Women Extra Strength Scalp Foam, Regaine For Women Regular Strength
- Italy
- Aloxidil, Carexidil, Loniten, Minovital, Minoxidil Biorga, Minoximen, Phalanx, Regaine, Scevadil, Trefostil
- Latvia
- Minoxidil Auxilia, Minoxidil Inteli, Regaine
- Lithuania
- Minoxidil Auxilia, Minoxidil Inteli, Regaine
- Luxembourg
- Alopexy, Minoxidil Biorga, Minoxidil Leman
- Malta
- Minorga, Minoxidil Nio, Minoxidil Poa Pharma, Minoxidil Torrent, Regaine Extra Strength, Regaine For Men Extra Strength Scalp Foam, Tricovivax
- Netherlands
- Lonnoten, Minoxidil Bipharma, Minoxidil Fagron Nl, Minoxidil Hgs, Minoxidil Intermed, Minoxidil Linn, Minoxidil Teva, Minoxidil Xiromed
- Norway
- Minoksidil Norfri, Recrea Forte, Rylaxtol
- Poland
- Agrocia, Alocutan, Alopexy, Dx2lek, Himedic Pianka, Loxon, Minorga, Minovivax, Minoxidil Dla Kobiet Doppelherz, Minoxidil Doppelherz Dla, Minoxidil Medinfar, Minoxidilum Torrent, Piloxidil
- Portugal
- Alorexyl, Folcare, Mantai "acção Intermédia", Mantai "forte", Minox, Minoxidil Biorga, Noage, Ocicol, Tricovivax, Trinox, Zeldilon
- Romania
- Alopexy, Hairgrow, Minorga, Minoxidil Medinfar, Regaine
- Slovakia
- Minorga, Minoxidil Miowell
- Slovenia
- Regaine
- Spain
- Alocutan, Aloxidil, Dinaxil, Lacovin, Loniten, Minogal, Minoxidil Biorga, Minoxidil Cinfa, Minoxidil Galenicumderma, Minoxidil Viñas, Normopil, Regaine, Regaxidil
- Sweden
- Lotorin, Minoxidil Abece, Minoxidil Apofri, Minoxidil Forte Apofri, Minoxidil Forte Net, Minoxidil Forte Orifarm, Minoxidil Net, Minoxidil Orifarm, Rogaine, Roquinna, Rylaxtol
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Minoxidil (Par Health USA, LLC) – Prescribing Information, 2026-06-11. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f3800f0-b6da-4dfe-8c32-39bb5eb0262a
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.